Transplantation tolerance: the big picture. Where do we stand, where should we go?
A major goal in organ transplantation has been to safely exploit the natural processes of immune tolerance in order to minimize the dose and duration of drug immunosuppression. In this commentary, I argue that we can learn from how tumours avoid rejection, to evolve a three-stage tolerance-inducing...
Váldodahkki: | Waldmann, H |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
Wiley
2017
|
Geahča maid
-
Transplantation tolerance-where do we stand?
Dahkki: Waldmann, H
Almmustuhtton: (1999) -
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
Dahkki: Inês Barros, et al.
Almmustuhtton: (2020-10-01) -
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
Dahkki: Aqeel M. Alenazi, et al.
Almmustuhtton: (2023-04-01) -
ColVI myopathies: where do we stand, where do we go?
Dahkki: Allamand Valérie, et al.
Almmustuhtton: (2011-09-01) -
Training Needs Assessment: Where We Are and Where We Should Go
Dahkki: Rodrigo Rezende Ferreira, et al.
Almmustuhtton: (2013-01-01)